Sylvester Comprehensive Cancer Center shared a post on LinkedIn:
“A new gene editing study offers hope for people with diseases affecting the mitochondria. Scientists corrected a mutation in a preclinical model, a key step toward treatments. Led by Dr. Carlos Moraes, this team science effort moves us closer to real-world solutions!”